Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Sarah Brooks Minor"'
Autor:
Brittany Helton, Ashley MacWhinnie, Sarah Brooks Minor, Thomas P. Lodise, Kelly D. Rafferty, Steven L. Allison
Publikováno v:
Drugs - Real World Outcomes, Vol 7, Iss S1, Pp 20-29 (2020)
Abstract Objectives Acute bacterial skin and soft tissue infections (ABSSSIs) are a leading cause of presentation to the emergency department (ED). This study aimed to determine the potential impact of utilizing oritavancin in the ED or observation u
Externí odkaz:
https://doaj.org/article/65a7b99ad6154d639041e713ae36558e
Autor:
Thomas P. Lodise, Steven L Allison, Sarah Brooks Minor, Ashley MacWhinnie, Kelly D Rafferty, Brittany Helton
Publikováno v:
Drugs-Real World Outcomes
Drugs-Real World Outcomes, Vol 7, Iss S1, Pp 20-29 (2020)
Drugs-Real World Outcomes, Vol 7, Iss S1, Pp 20-29 (2020)
Objectives Acute bacterial skin and soft tissue infections (ABSSSIs) are a leading cause of presentation to the emergency department (ED). This study aimed to determine the potential impact of utilizing oritavancin in the ED or observation unit (OBS)
Autor:
Christopher Polk, William E. Anderson, Sarah Brooks Minor, Gerald A. Capraro, Danya Roshdy, Renee Ackley, Jacqueline Meredith
Publikováno v:
Antimicrobial Agents and Chemotherapy. 64
The comparative efficacy of ceftazidime-avibactam and meropenem-vaborbactam for treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections remains unknown. This was a multicenter, retrospective cohort study of adults with CRE infections wh
Publikováno v:
Open Forum Infectious Diseases
Background Carbapenem-resistant organisms (CROs) represent an urgent public health threat and associated with mortality rates up to 60%. Pharmacotherapy for these infections remain challenging and historically included multiple agents. Meropenem/vabo
Publikováno v:
Open Forum Infectious Diseases
Background Eravacycline (ERV) is a next-generation tetracycline approved for complicated intra-abdominal infections (cIAI) with in-vitro activity to multidrug-resistant organisms such as carbapenem resistant Enterobacteriaceae, extended spectrum beta
Publikováno v:
Open Forum Infectious Diseases
Background Antimicrobial resistance in Stenotrophomonas maltophilia is one of the most complex among Gram-negatives. Presence of regulating non-specific antimicrobial class efflux pumps and chromosomal encoded L1 metallo-betalactamase (Ambler Class B
Autor:
Julia Logan Rutkowski, Steven L Allison, Kelly D Rafferty, Sarah Brooks Minor, Victor Herrera
Publikováno v:
Open Forum Infectious Diseases
Background Antibiotic overuse continues to be a challenge in the acute care setting. At AdventHealth Orlando (AHO), pharmacy-led prospective audit with feedback (PAAF) has been the primary stewardship tool. Despite PAAF and criteria for use, overall
Autor:
Jose Alexander, Sarah Brooks Minor
Publikováno v:
Open Forum Infectious Diseases
Background CREs are feared pathogens with resistance occurring through the production of carbapenemases. Identification of carbapenemase-producing (CP) organisms assists with proper antimicrobial selection of commonly used agents, such as ceftazidime
Autor:
Renee Ackley, Gerald A. Capraro, Jacqueline Isip, Danya Roshdy, Sarah Brooks Minor, Christopher Polk, William E Anderson, Amanda L Elchynski
Publikováno v:
Open Forum Infectious Diseases
Background Options for treatment of carbapenem-resistant Enterobacteriaceae (CRE) infections were historically limited to antibiotics with limited efficacy and significant toxicities. Ceftazidime/avibactam (CA) and meropenem/vaborbactam (MV) are supe
Publikováno v:
Open Forum Infectious Diseases
Background Respiratory infection due to Achromobacter species has been increasingly more common, especially in patients with cystic fibrosis (CF). Recurrent infections in these patients contribute to significant morbidity and mortality as well as lea